Steward Partners Investment Advisory’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Steward Partners Investment Advisory’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-564	Closed	-$13.6K	–	3419
2023 Q1	$13.6K	Buy	564 +500	+781%	+$6.28K	﹤0.01%	2424
2022 Q4	$676	Sell	64 -386	-86%	-$3.12K	﹤0.01%	3165
2022 Q3	$2K	Hold	450	–	–	﹤0.01%	3085
2022 Q2	$2K	Buy	+450	New	+$2.13K	﹤0.01%	3066

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Steward Partners Investment Advisory's PRVB Position: Q2 2023 in Review

Steward Partners Investment Advisory sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 564 shares — an estimated $13.6K sold.

Steward Partners Investment Advisory first reported a position in PRVB in Q2 2022 and held it in 4 quarters. The position peaked at $13.6K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Steward Partners Investment Advisory reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Steward Partners Investment Advisory sold 564 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $13.6K.
Steward Partners Investment Advisory first reported a position in Provention Bio, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Steward Partners Investment Advisory's Provention Bio, Inc. Common Stock position peaked at $13.6K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2023, filed 14 Aug 2023.